CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21)Noriyoshi Iriyama, Tomoki Naoe, Masatomo Takahashi et al.|Leukemia Research|2013Cited by 58
Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcomeNoriyoshi Iriyama, Tomoki Naoe, Norio Asou et al.|Annals of Hematology|2014Cited by 12
Expression of CD56 Is an Independent Prognostic Factor to Predict Relapse in Acute Myeloid Leukemia with t(8;21): Results of Japan Adult Leukemia Study Group (JALSG) AML97 Protocol.Noriyoshi Iriyama, Tomoki Naoe, Tomohiko Taki et al.|Blood|2012Cited by 0
Prognostic Impact of Chromosomal Variation in Patients with Acute Promyelocytic Leukemia (APL); Analysis of 775 Cases Enrolled in the Japan Adult Leukemia Study Group APL StudiesMiwa Adachi, Tomoki Naoe, Akihiro Takeshita et al.|Blood|2014Cited by 0